Annual Operating Profit
-$566.51 M
+$78.22 M+12.13%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual operating income is -$566.51 million, with the most recent change of +$78.22 million (+12.13%) on December 31, 2023.
- During the last 3 years, NVAX annual operating profit has fallen by -$149.79 million (-35.95%).
- NVAX annual operating profit is now -13025.83% below its all-time high of -$4.32 million, reached on December 31, 2005.
Performance
NVAX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$134.02 M
-$295.02 M-183.24%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly operating income is -$134.02 million, with the most recent change of -$295.02 million (-183.24%) on September 30, 2024.
- Over the past year, NVAX quarterly operating profit has dropped by -$8.39 million (-6.68%).
- NVAX quarterly operating profit is now -164.03% below its all-time high of $209.29 million, reached on March 31, 2022.
Performance
NVAX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$301.42 M
-$8.39 M-2.86%
September 30, 2024
Summary
- As of February 7, 2025, NVAX TTM operating income is -$301.42 million, with the most recent change of -$8.39 million (-2.86%) on September 30, 2024.
- Over the past year, NVAX TTM operating profit has increased by +$325.40 million (+51.91%).
- NVAX TTM operating profit is now -32171.84% below its all-time high of -$934.00 thousand, reached on March 31, 2006.
Performance
NVAX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
NVAX Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +12.1% | -6.7% | +51.9% |
3 y3 years | -36.0% | +83.8% | +82.1% |
5 y5 years | -225.7% | -485.3% | -168.5% |
NVAX Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +66.4% | -164.0% | +83.8% | -2.9% | +82.1% |
5 y | 5-year | -337.1% | +66.4% | -164.0% | +83.8% | -225.4% | +82.1% |
alltime | all time | <-9999.0% | +66.4% | -164.0% | +83.8% | <-9999.0% | +82.1% |
Novavax Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$134.02 M(-183.2%) | -$301.42 M(+2.9%) |
Jun 2024 | - | $161.00 M(-211.2%) | -$293.03 M(-26.5%) |
Mar 2024 | - | -$144.83 M(-21.1%) | -$398.57 M(-29.6%) |
Dec 2023 | -$566.51 M(-12.1%) | -$183.57 M(+46.1%) | -$566.51 M(-9.6%) |
Sep 2023 | - | -$125.63 M(-326.5%) | -$626.82 M(-0.2%) |
Jun 2023 | - | $55.46 M(-117.7%) | -$628.38 M(-46.1%) |
Mar 2023 | - | -$312.77 M(+28.2%) | -$1.17 B(+81.0%) |
Dec 2022 | -$644.74 M(-61.8%) | -$243.88 M(+91.7%) | -$644.74 M(-47.4%) |
Sep 2022 | - | -$127.19 M(-73.7%) | -$1.23 B(-12.8%) |
Jun 2022 | - | -$482.96 M(-330.8%) | -$1.41 B(+10.8%) |
Mar 2022 | - | $209.29 M(-125.4%) | -$1.27 B(-24.8%) |
Dec 2021 | -$1.69 B(+304.7%) | -$824.97 M(+168.6%) | -$1.69 B(+61.5%) |
Sep 2021 | - | -$307.14 M(-11.2%) | -$1.04 B(+12.2%) |
Jun 2021 | - | -$345.83 M(+65.8%) | -$931.26 M(+54.6%) |
Mar 2021 | - | -$208.63 M(+14.1%) | -$602.45 M(+44.6%) |
Dec 2020 | -$416.72 M(+221.5%) | -$182.85 M(-5.7%) | -$416.72 M(+58.7%) |
Sep 2020 | - | -$193.94 M(+1039.0%) | -$262.57 M(+183.5%) |
Jun 2020 | - | -$17.03 M(-25.6%) | -$92.63 M(-17.5%) |
Mar 2020 | - | -$22.90 M(-20.2%) | -$112.27 M(-13.4%) |
Dec 2019 | -$129.60 M(-25.5%) | -$28.70 M(+19.6%) | -$129.60 M(-12.1%) |
Sep 2019 | - | -$24.00 M(-34.5%) | -$147.40 M(-10.8%) |
Jun 2019 | - | -$36.67 M(-8.8%) | -$165.30 M(-3.1%) |
Mar 2019 | - | -$40.22 M(-13.5%) | -$170.63 M(-1.9%) |
Dec 2018 | -$173.92 M(+1.3%) | -$46.51 M(+11.0%) | -$173.92 M(-0.7%) |
Sep 2018 | - | -$41.90 M(-0.2%) | -$175.19 M(+0.2%) |
Jun 2018 | - | -$41.99 M(-3.5%) | -$174.92 M(+0.3%) |
Mar 2018 | - | -$43.51 M(-8.9%) | -$174.40 M(+1.6%) |
Dec 2017 | -$171.71 M(-36.2%) | -$47.78 M(+14.8%) | -$171.71 M(-3.5%) |
Sep 2017 | - | -$41.63 M(+0.4%) | -$177.97 M(-10.9%) |
Jun 2017 | - | -$41.47 M(+1.6%) | -$199.65 M(-14.9%) |
Mar 2017 | - | -$40.83 M(-24.5%) | -$234.68 M(-12.8%) |
Dec 2016 | -$269.11 M(+71.2%) | -$54.05 M(-14.6%) | -$269.11 M(-8.5%) |
Sep 2016 | - | -$63.31 M(-17.2%) | -$293.97 M(+11.4%) |
Jun 2016 | - | -$76.50 M(+1.6%) | -$263.86 M(+26.7%) |
Mar 2016 | - | -$75.26 M(-4.6%) | -$208.18 M(+32.4%) |
Dec 2015 | -$157.24 M(+87.9%) | -$78.90 M(+137.7%) | -$157.24 M(+42.9%) |
Sep 2015 | - | -$33.20 M(+59.4%) | -$110.00 M(+13.9%) |
Jun 2015 | - | -$20.82 M(-14.4%) | -$96.59 M(+3.2%) |
Mar 2015 | - | -$24.31 M(-23.2%) | -$93.62 M(+11.9%) |
Dec 2014 | -$83.69 M(+59.6%) | -$31.66 M(+60.0%) | -$83.69 M(+26.3%) |
Sep 2014 | - | -$19.79 M(+10.9%) | -$66.28 M(+7.3%) |
Jun 2014 | - | -$17.85 M(+24.1%) | -$61.77 M(+8.7%) |
Mar 2014 | - | -$14.38 M(+0.9%) | -$56.81 M(+8.4%) |
Dec 2013 | -$52.43 M(+76.8%) | -$14.25 M(-6.7%) | -$52.44 M(+10.0%) |
Sep 2013 | - | -$15.28 M(+18.5%) | -$47.68 M(+21.5%) |
Jun 2013 | - | -$12.90 M(+28.9%) | -$39.25 M(+21.9%) |
Mar 2013 | - | -$10.01 M(+5.4%) | -$32.20 M(+8.6%) |
Dec 2012 | -$29.66 M(+37.5%) | -$9.49 M(+38.6%) | -$29.67 M(+21.4%) |
Sep 2012 | - | -$6.85 M(+17.0%) | -$24.43 M(+13.4%) |
Jun 2012 | - | -$5.86 M(-21.6%) | -$21.55 M(-0.3%) |
Mar 2012 | - | -$7.47 M(+75.3%) | -$21.61 M(+0.2%) |
Dec 2011 | -$21.58 M(-43.9%) | -$4.26 M(+7.3%) | -$21.58 M(-11.4%) |
Sep 2011 | - | -$3.97 M(-33.0%) | -$24.35 M(-21.3%) |
Jun 2011 | - | -$5.92 M(-20.3%) | -$30.92 M(-10.3%) |
Mar 2011 | - | -$7.43 M(+5.7%) | -$34.47 M(-10.5%) |
Dec 2010 | -$38.49 M | -$7.03 M(-33.3%) | -$38.49 M(-15.6%) |
Sep 2010 | - | -$10.54 M(+11.3%) | -$45.62 M(+5.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2010 | - | -$9.47 M(-17.3%) | -$43.34 M(+3.9%) |
Mar 2010 | - | -$11.45 M(-19.1%) | -$41.70 M(+11.5%) |
Dec 2009 | -$37.38 M(+8.8%) | -$14.15 M(+71.3%) | -$37.38 M(+15.2%) |
Sep 2009 | - | -$8.26 M(+5.5%) | -$32.44 M(-4.3%) |
Jun 2009 | - | -$7.83 M(+9.7%) | -$33.90 M(-1.1%) |
Mar 2009 | - | -$7.14 M(-22.5%) | -$34.28 M(-0.2%) |
Dec 2008 | -$34.36 M(+13.5%) | -$9.21 M(-5.3%) | -$34.36 M(+20.8%) |
Sep 2008 | - | -$9.73 M(+18.6%) | -$28.45 M(+1.7%) |
Jun 2008 | - | -$8.20 M(+13.6%) | -$27.98 M(-1.8%) |
Mar 2008 | - | -$7.22 M(+119.1%) | -$28.50 M(-2.1%) |
Dec 2007 | -$30.27 M(+43.4%) | -$3.30 M(-64.4%) | -$29.12 M(-0.2%) |
Sep 2007 | - | -$9.26 M(+6.1%) | -$29.17 M(+13.9%) |
Jun 2007 | - | -$8.72 M(+11.3%) | -$25.61 M(+7.1%) |
Mar 2007 | - | -$7.84 M(+134.1%) | -$23.92 M(+13.3%) |
Dec 2006 | -$21.12 M(+389.2%) | -$3.35 M(-41.2%) | -$21.12 M(+240.4%) |
Sep 2006 | - | -$5.69 M(-19.1%) | -$6.20 M(+125.8%) |
Jun 2006 | - | -$7.04 M(+39.8%) | -$2.75 M(+194.1%) |
Mar 2006 | - | -$5.04 M(-143.5%) | -$934.00 K(-78.4%) |
Dec 2005 | -$4.32 M(-82.4%) | $11.56 M(-616.9%) | -$4.32 M(-83.3%) |
Sep 2005 | - | -$2.24 M(-57.2%) | -$25.79 M(-0.3%) |
Jun 2005 | - | -$5.22 M(-37.9%) | -$25.87 M(-7.6%) |
Mar 2005 | - | -$8.42 M(-15.0%) | -$27.98 M(+14.4%) |
Dec 2004 | -$24.46 M(+52.4%) | -$9.91 M(+327.1%) | -$24.46 M(+38.9%) |
Sep 2004 | - | -$2.32 M(-68.4%) | -$17.62 M(-3.5%) |
Jun 2004 | - | -$7.34 M(+49.9%) | -$18.26 M(+17.4%) |
Mar 2004 | - | -$4.90 M(+60.0%) | -$15.55 M(-3.1%) |
Dec 2003 | -$16.05 M(-25.5%) | -$3.06 M(+3.4%) | -$16.05 M(-6.0%) |
Sep 2003 | - | -$2.96 M(-36.1%) | -$17.09 M(-17.1%) |
Jun 2003 | - | -$4.63 M(-14.2%) | -$20.60 M(-4.1%) |
Mar 2003 | - | -$5.40 M(+32.0%) | -$21.49 M(-0.3%) |
Dec 2002 | -$21.56 M(+132.9%) | -$4.09 M(-36.8%) | -$21.56 M(+5.1%) |
Sep 2002 | - | -$6.48 M(+17.5%) | -$20.52 M(+25.0%) |
Jun 2002 | - | -$5.51 M(+0.7%) | -$16.41 M(+30.5%) |
Mar 2002 | - | -$5.47 M(+79.6%) | -$12.58 M(+35.9%) |
Dec 2001 | -$9.26 M(-27.4%) | -$3.05 M(+28.5%) | -$9.26 M(-18.0%) |
Sep 2001 | - | -$2.37 M(+41.0%) | -$11.29 M(-8.2%) |
Jun 2001 | - | -$1.68 M(-21.9%) | -$12.29 M(-8.5%) |
Mar 2001 | - | -$2.15 M(-57.7%) | -$13.44 M(+5.5%) |
Dec 2000 | -$12.74 M(+177.0%) | -$5.08 M(+50.6%) | -$12.74 M(+45.5%) |
Sep 2000 | - | -$3.38 M(+19.4%) | -$8.76 M(+21.9%) |
Jun 2000 | - | -$2.83 M(+94.3%) | -$7.18 M(+39.3%) |
Mar 2000 | - | -$1.46 M(+32.3%) | -$5.16 M(+12.1%) |
Dec 1999 | -$4.60 M(-11.5%) | -$1.10 M(-38.9%) | -$4.60 M(-11.5%) |
Sep 1999 | - | -$1.80 M(+125.0%) | -$5.20 M(+10.6%) |
Jun 1999 | - | -$800.00 K(-11.1%) | -$4.70 M(-9.6%) |
Mar 1999 | - | -$900.00 K(-47.1%) | -$5.20 M(0.0%) |
Dec 1998 | -$5.20 M(+8.3%) | -$1.70 M(+30.8%) | -$5.20 M(+13.0%) |
Sep 1998 | - | -$1.30 M(0.0%) | -$4.60 M(+2.2%) |
Jun 1998 | - | -$1.30 M(+44.4%) | -$4.50 M(0.0%) |
Mar 1998 | - | -$900.00 K(-18.2%) | -$4.50 M(-4.3%) |
Dec 1997 | -$4.80 M(-12.7%) | -$1.10 M(-8.3%) | -$4.70 M(-13.0%) |
Sep 1997 | - | -$1.20 M(-7.7%) | -$5.40 M(+3.8%) |
Jun 1997 | - | -$1.30 M(+18.2%) | -$5.20 M(0.0%) |
Mar 1997 | - | -$1.10 M(-38.9%) | -$5.20 M(0.0%) |
Dec 1996 | -$5.50 M | -$1.80 M(+80.0%) | -$5.20 M(+52.9%) |
Sep 1996 | - | -$1.00 M(-23.1%) | -$3.40 M(+41.7%) |
Jun 1996 | - | -$1.30 M(+18.2%) | -$2.40 M(+118.2%) |
Mar 1996 | - | -$1.10 M | -$1.10 M |
FAQ
- What is Novavax annual operating income?
- What is the all time high annual operating profit for Novavax?
- What is Novavax annual operating profit year-on-year change?
- What is Novavax quarterly operating income?
- What is the all time high quarterly operating profit for Novavax?
- What is Novavax quarterly operating profit year-on-year change?
- What is Novavax TTM operating income?
- What is the all time high TTM operating profit for Novavax?
- What is Novavax TTM operating profit year-on-year change?
What is Novavax annual operating income?
The current annual operating profit of NVAX is -$566.51 M
What is the all time high annual operating profit for Novavax?
Novavax all-time high annual operating income is -$4.32 M
What is Novavax annual operating profit year-on-year change?
Over the past year, NVAX annual operating income has changed by +$78.22 M (+12.13%)
What is Novavax quarterly operating income?
The current quarterly operating profit of NVAX is -$134.02 M
What is the all time high quarterly operating profit for Novavax?
Novavax all-time high quarterly operating income is $209.29 M
What is Novavax quarterly operating profit year-on-year change?
Over the past year, NVAX quarterly operating income has changed by -$8.39 M (-6.68%)
What is Novavax TTM operating income?
The current TTM operating profit of NVAX is -$301.42 M
What is the all time high TTM operating profit for Novavax?
Novavax all-time high TTM operating income is -$934.00 K
What is Novavax TTM operating profit year-on-year change?
Over the past year, NVAX TTM operating income has changed by +$325.40 M (+51.91%)